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Introduction 
Vitamin B6 (B6) is an essential water-soluble vitamin required for normal growth and 
development in mammals. B6 is the collective term for metabolically and functionally compounds 
including pyridoxine (PN), pyridoxal (PL) and pyridoxamine (PM), and their phosphorylated forms 
pyridoxal 5′-phosphate (PLP), pyridoxine 5′-phosphate (PNP), and pyridoxamine 5′-phosphate (PMP). 
PLP is the biologically active form of B6, acts as a co-factor in over 140 distinct enzyme reactions that 
are involved in the metabolisms of proteins, lipids, and carbohydrates, neurotransmitters, nucleic acids, 
one carbon units, and immune modulatory metabolites and others. After intestinal absorption, most of 
B6 ingested is transported to the liver and taken up by facilitated diffusion. After being phosphorylated 
by pyridoxal kinase, PNP and PMP are converted to PLP. 
Beyond its the role as the co-factor, B6 has the preventive roles in certain diseases including brain 
diseases such as Parkinson’s disease (PD), Schizophrenia, Alzheimer disease (AD) and autoimmune 
diseases such as rheumatic arthritis (RA). B6 also have important role in heart diseases such as 
cardiovascular disease (CVD), atherosclerosis, and stroke and colon diseases such as irritable bowel 
disease (IBS), intestinal bowel diseases (IBD), colitis, and colon cancer (CRC). However, the 
underlying mechanisms of these preventive effects of B6 are still unclear. In this study, I focused on the 
preventive effects of B6 on colon and heart diseases.  
 
Effect of dietary supplemental vitamin B6 and gender difference on colon luminal environment 
Accumulating studies have suggested the preventive role of dietary B6 on colon diseases. B6 has 
the potential mechanisms to prevent from colon diseases include reducing cell proliferation, oxidative 
stress, inflammation, angiogenesis, and increased fecal mucins. It has been reported that The status of 
B6 is affected by gender difference. There is growing evidence that the incidence of colon diseases is 
affected by gender difference. However, the underlying mechanisms of the effects of gender on colon 
diseases are still unclear. 
An understanding of the colon luminal environment is essential to reveal the effects of dietary B6 
and gender difference on colon diseases. The important factors in the luminal environment includes 
intestinal mucins, IgA, microflora, etc. In this study, I hypothesized that gender difference modulates 
the colon luminal environment, which is dependent upon B6 status. To investigate this hypothesis, 
male and female rats were fed the diet containing 1 mg (low), 7 mg (recommended), or 35 mg (high) 
pyridoxine HCl/kg diet for 6 weeks.  
As a result, dietary B6 significantly increased fecal mucins and the effect was particularly 
profound in the female rats. The fecal mucin levels were significantly correlated with colon free 
threonine and serine and with gene expression of colon MUC16, implying that the combined effect of 
gender and dietary B6 on fecal mucins was mediated by the alteration in the levels of such amino acids 
and MUC16 expression. Meanwhile, this study indicated no effect of gender and B6 on fecal IgA. 
Mucins are considered to play a beneficial role in intestinal barrier function and in preventing colon 
cancer. Thus, dietary B6 and gender may modulate colon luminal environment through mucin 
production, but not IgA production. The abundances of cecal and fecal Akkermansia muciniphila 
(mucin degrader) were unaffected. Thus, Akkermansia muciniphila is not likely to be responsible for 
the alteration in mucins. This study further showed the significant effects of gender difference on 
colon free amino acids such as threonine, ornithine, asparagine/aspartate ratio, glutamine/glutamate 
ratio, on cecal and fecal Lactobacillus spp. abundance and colon gene expressions of MUC16 and 
TLR8, the factors relating to colon health and diseases. Accordingly, my study suggests that dietary B6 
and gender difference may have an impact on colon diseases by modulating these parameters.  
 
Effect of dietary supplemental vitamin B6 on the levels of anti-disease metabolites in heart 
Several epidemiological studies have shown the positive benefits of B6 to heart diseases. The 
suggested mechanisms responsible for the preventive effects of B6 against heart diseases include 
homocysteine, purinergic receptors signaling, inflammation, and kynurenine pathway. However, the 
exact mechanisms of the effects of B6 are still unclear. 
In this study, I hypothesized that dietary B6 improves heart dysfunction by modulating amino acid 
metabolisms. To examine this hypothesis, I conducted metabolomics analysis to investigated 
concentrations of metabolites of the heart in rats fed a diet containing 1 mg (low) or 35 mg (high) 
pyridoxine (PN) HCl/kg for six weeks. 
As a result, there were over 500 metabolites detected, and 21 metabolites were affected by dietary 
B6. the first group affected by supplemental B6 was the metabolites related to carnosine were 
carnosine, anserine, homocarnosine, and β-alanine. The second group was the amino acids such as 
alanine, serine, isoleucine, leucine, valine, methionine. The third group was the metabolite in the TCA 
cycle and urea cycles such as malic acid, fumaric acid, argininosuccinic acid, and ornithine. The fourth 
group is the other metabolites such as gamma-aminobutyric acid (GABA), histamine, 
1H-Imidazole-4-propionic acid, γ-butyrobetaine, carnitine, adenine, and FAD. These metabolites 
except for ornithine were significantly increased by high B6 diet, whereas ornithine was increased by 
the low B6 diet. Among those metabolites, carnosine, anserine, β-alanine, GABA, histamine, fumaric 
acid, malic acid, carnitine, and adenine are known to have heart-protective effects. 
Carnosine is synthesized from histidine and β-alanine by carnosine synthase. Meanwhile anserine 
is produced from carnosine by carnosine-N-methyltransferase. In this study, high B6 diet markedly 
elevated the concentration of carnosine, anserine and their precursor, β-alanine. There was strong 
correlation of β-alanine with carnosine and anserine levels. Thus, increased carnosine and anserine by 
dietary B6 might be, at least in part, caused by increased β-alanine.  
availability of GABA affects homocarnosine synthesis. In this study, homocarnosine levels had a 
strong correlation with GABA levels. Thus, increased homocarnosine by dietary B6 might relate to 
higher GABA. 
Histamine is derived from the decarboxylation of histidine, a reaction is catalyzed by the enzyme 
histidine decarboxylase, a PLP-dependent enzyme. Thus, the higher histamine levels by high B6 diet 
might be mediated by higher conversion from histidine. 
The concentration of β-alanine and GABA were increased by dietary B6 and inversely associated 
with ornithine concentration. Ornithine is converted by ornithine decarboxylase to β-alanine in 
polyamines pathway. Meanwhile GABA is synthesized by aminotransferase from ornithine through 
glutamic acid pathways. Thus, high B6 diet might increase the formation of β-alanine and GABA from 
ornithine through the two pathways. 
Further HPLC analysis showed that the recommended and high levels of B6 in the diet markedly 
elevated the concentration of GABA and histamine compared to low B6 diet. Meanwhile, there was no 
significant difference in the concentrations of GABA and histamine between the recommended and 
high levels of B6 diet. These results imply that the elevations in GABA and histamine can be produced 
by the supplementation of B6 to the low B6 diet, but not by the supplementation to normal diet of 
recommended B6 level.  
γ-Butyrobetaine is a precursor for carnitine. Therefore, the higher concentration of 
γ-butyrobetaine by high B6 diet might be ascribed to the increased concentration of carnitine. 
The underlying mechanisms of the alterations of other metabolites such as alanine, serine, 
isoleucine, leucine, valine, methionine, fumaric acid, malic acid, argininosuccinic acid, butyrobetaine, 
carnitine, adenine and FAD by dietary B6 are still unclear at present. 
The results suggest that the possible mechanism of the heart-protective effect of B6 is ascribed to 
increased heart-protective metabolites. My study explains the reason why adequate B6 status is 
essential to maintain the optimal heart health.  
 
Conclusion  
These study demonstrated supplemental B6 increased fecal mucins in rats in a gender-dependent 
manner. The mechanisms of the effect of dietary B6, combined with gender difference, may be 
mediated by modulating colon free threonine and serine and gene expression of MUC16. During this 
study, I found the gender difference modulated several parameters, including colon free amino acids, 
mucins, microflora, and expressions of MUC16 and TLR8, important to colon diseases. The results 
imply that the effects of gender on colon diseases are mediated through alterations in such parameters. 
Further, I found the increased levels of several heart-protective metabolites such as carnosine, anserine, 
GABA, histamine, etc. in the heart of rats by supplemental B6. The possible mechanisms of increases 
in carnosine, anserine, GABA and histamine by supplemental B6 were discussed. Collectively, the 
results imply the novel mechanisms of anti-heart disease effect of dietary B6 by elevating such 
protective metabolites. Taken together, my Ph.D. studies give an insight into the understanding of the 
possible mechanisms of the beneficial effects of dietary B6 on colon and heart.  
 
 
 
 
